Full Year Results - 12 August 2015
Join CSL Limited CEO Paul Perreault and CFO Gordon Naylor for a live webcast from 11am
Our Corporate Responsibility 2014
View Our Corporate Responsibility 2014
Update on Novartis influenza vaccines acquisition
CSL has secured the necessary approvals required ...
Competitive Advanced Manufacturing - Quite within Reach for Australia
Securing a globally competitive locally-based ...
U.S. FDA Accepts for Review CSL Behring’s BLA for its Novel rVIII-SingleChain Therapy for Patients with Haemophilia A
In the pivotal clinical trial, ...